Immuneering Statistics
NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.38-0.07 (-2.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immuneering by the numbers
Immuneering has a market capitalization of $218.9 million based on 64.76M shares outstanding. With trailing EPS of $-0.92, Immuneering is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.9% below its 50-day average and 28.3% below its 200-day average.
Average daily trading volume is 747.66K shares, or about $2.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMRX valuation vs. peer median
| Metric | IMRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $218.90M | $215.61M | +2% |
| Avg. volume | 747.66K | 954.92K | -22% |
Peer median across 8 companies: RCKT, KROS, PYXS, ENTA, ARCT, CYPH, VNDA, FTH.
Valuation
- Market cap
- $218.90M
- EPS (TTM)
- $-0.92
- Shares outstanding
- 64.76M
Price and trading
- Previous close
- 3.45
- Open
- 3.38
- Day range
- 3.29 – 3.54
- 52-week range
- 3.29 – 8.48
- 52-week change
- -53.70%
- Beta
- —
- Volume
- 1.45M
- Average volume
- 747.66K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 218.90M
- Forward Pe
- -2.06
- Eps
- -0.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.48
- Week52 Low
- 3.29
- Avg Volume
- 747.66K
- Shares Outstanding
- 64.76M
- Ma50
- 3.88
- Ma200
- 4.71
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -60.14%
- Pct From52w Low
- 2.77%